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Abstract 
As a ubiquitous intracellular messenger ion, calcium is involved in many critical 
biochemical processes in the cell. In cardiomyocytes, Ca2+ interacts with a variety of 
calcium-sensing proteins and regulates cardiac pacemaking, excitability and contractility. 
This study examined two typical calcium-sensing proteins: calpain and Ca2+/calmodulin-
dependent protein kinase II (CaMKII). Drosophila melanogaster was used as a model to 
explore the roles of these proteins in cardiomyocyte and how their dysregulation affects 
cardiac function. We show here that calpain mutations, calpain knockdowns, and 
CaMKII knockdown result in increased cardiac frequency and rhythmicity. In contrast, 
mutation in CaMKII causes a decreased cardiac frequency and rhythmicity. The findings 
deepened our understanding of the roles of calpain and CaMKII in heart cells and how 
their dysregulation could affect the heartbeat.   
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Introduction 
Cardiac physiology has been a major focus in biomedical research. From the perspective 
of basic biology, cardiac muscle cells, or cardiomyocytes, are highly specialized in 
pacemaking and synchronizing contraction-relaxation cycles. They share the same 
contraction mechanism with skeletal muscles, and their cell signaling transduction 
mechanisms are similar to those seeing in other tissues. Thus exploring the 
cardiomyocyte provides an opportunity to understand many universal cellular 
machineries. From the perspective of translational medicine, more than 26.6 million non-
institutionalized adults in the United States are currently diagnosed with cardiovascular 
disease (Rothwell et al. 2012). With almost 600,000 deaths each year, cardiovascular 
disease is the leading cause of death in the country (Murphy et al. 2013). Studying 
cardiac pathophysiology is thus crucial for the understanding the etiology of the 
cardiovascular disease and the development of targeted therapeutics.   
In the heart, calcium (Ca2+) plays the central role in pacemaking and contractility 
(Bers 2000; Bers 2008). Cardiac pacemaker is an ensemble of ion channels that produces 
rhythmic heartbeat in an oscillatory manner (Giles et al. 1986; Bodmer et al. 2004). 
Cardiac action potential is generated by Ca2+ entering the cell through L-type (Ica,L) and 
T-type (Ica,T) calcium channels. Triggered by Ica,T, Ca2+ is also released from sarcoplasmic 
reticulum through ryanodine receptors, contributing to the pacemaking (Bodmer et al. 
2004). Contractility, on the other hand, depends upon cardiomyocyte excitation-
contraction coupling. During the excitation-contraction cycle, Ca2+ enters the cell through 
L-type Ca2+ channels. This Ca2+ influx triggers the Ca2+-induced Ca2+ release from 
sarcoplasmic reticulum through ryanodine-receptors. The increased cytosolic Ca2+ 
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concentration allows Ca2+ to bind to the myofilament protein troponin C, turning on the 
muscle contractile machinery. After contraction, Ca2+ is transported out of the cytosol by 
sarcoplasmic reticulum Ca2+-ATPase (SERCA), sarcolemmal Na+/Ca2+ exchanger, 
sarcolemmal Ca2+-ATPase and mitochondrial Ca2+ uniport, initiating diastolic relaxation 
(Bers 2002).  
Apart from being directly involved in the pacemaking and excitation-contraction 
coupling, Ca2+ also closely interacts with a variety of calcium-sensing proteins and 
contributes to calcium homeostasis in cardiomyocyte. Malfunctioning of these proteins is 
central to the pathogenesis of cardiac disorders (Morgan 1991; Hasenfuss 1998; Wehrens 
and Marks 2004). One example is calpain, a group of cytosolic Ca2+-activated cysteine 
proteases. Once activated by Ca2+, conformational change takes place, allowing calpain 
to cleave other proteins at specific sites and produce large polypeptide fragments (Goll et 
al. 2003; Friedrich et al. 2004). In the cells, calpain is involved in cytoskeletal 
remodeling, proteolytic modification of components in signal transduction pathways, 
gene expression regulation, long-term potentiation, and apoptosis (Goll et al. 2003). 
Studies have found that calpain also plays an important role in cardiac pathophysiology. 
For instance, a study done by Brundel et al. (2002) shows that the calpain system is 
activated during atrial fibrillation. Patterson et al. (2011) and Letavernier et al. (2012) 
also suggested that calpain is involved in myocardial remodeling and heart failure. 
Specifically, through the activation of transcription factors such as NF-κB, calpain may 
lead to myocardial hypertrophy and inflammation. 
 Another key calcium-sensing protein, Ca2+/calmodulin-dependent protein kinase 
II (CaMKII) also closely regulates Ca2+ transients (Dobrev and Nattel 2008). Once 
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activated by β-adrenergic stimulation, CaMKII phosphorylates L-type Ca2+ channels and 
increases the amplitude of the Ca2+ current (Bers 2002). During excitation-contraction 
coupling, CaMKII phosphorylates other calcium-handling proteins such as 
phospholamban and ryanodine receptors on the sarcoplasmic reticulum (Currie et al. 
2004). Recent findings also suggest that CaMKII regulates non-Ca2+ transporters such as 
sarcolemmal Na+ and K+ channels (Maier and Bers 2002). Several clinical studies have 
shown that CaMKII is up-regulated in the myocardium of patients with heart failure, 
activating inflammatory and hypertrophic transcriptional pathways (Schulman and Mark 
2010). Although much research has been done on calpain and CaMKII, studying how 
dysregulation of these proteins affects cardiac function would provide us a new 
perspective on their roles in cardiomyocyte. 
Drosophila melanogaster has been routinely used as a model organism for 
molecular, genetic and physiological studies due to its richly annotated genome sequence 
and various homologous genes found in vertebrates, including humans (Adams et al. 
2000). Specifically, genes that control Drosophila heart development and mechanisms 
that regulate its cardiac functions are conserved up through mammals, making it a 
valuable tool to study cardiac physiology (Curtis et al. 1999; Pandey and Nichols 2011). 
Furthermore, Drosophila can be easily anesthetized using carbon dioxide (Perron et al. 
1972), and its easily identifiable morphology allows us to study the phenotypic traits of 
various genetic mutations or knockdowns.  
The Drosophila heart is a dorsal tubular organ that pumps hemolymph, the 
equivalent of blood in mammals but lacking oxygen carrying pigments, from its caudal 
region of abdomen to the head (Rizki 1978; Curtis et al. 1999). The myogenic cardiac 
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pacemaker is located at the caudal end of the heart, sending peristaltic impulses anteriorly 
(Rizki 1978; Dowse et al. 1995; Johnson et al. 1997; Bodmer et al. 2004). During the first 
of its fifteen pupal stages, the pupa is translucent and immobile, allowing the heartbeat to 
be monitored and recorded optically (Curtis et al. 1999).  
In order to further understand the roles of calpain and CaMKII in the heart, and to 
test the effect of dysregulation of these proteins on the cardiac function, we used three 
mutant strains – CalpA and CalpB strains, which contain disrupted genes encoding 
calpain A and calpain B respectively, and the l(4)16 strain, which contains a lesion in the 
CaMKII locus (Johnson et al. 2002). We also created heart specific knockdown strains by 
crossing the female transgenic RNAi flies with male flies carrying GMH5-Gal4. GMH5-
Gal4 is a cardiac specific driver that belongs to the family of Upstream Activation 
Sequence (UAS). Due to its cardiac specificity, it only activates the transcription of 
double-stranded RNA (dsRNA) and leads to post-transcriptional gene knockdown 
through RNA interference mechanism in the cardiac region. As a result, these knockdown 
strains had reduced calpain A, calpain B, and CaMKII protein level, respectively, in the 
heart. Both the mutant and the knockdown strains were tested following the same 
protocols. Because previous studies have found that Drosophila cardiac frequency and 
rhythmicity are temperature-dependent (Rizki 1978; Dowse et al. 1995; Jennings et al. 
2009), we tested the fly heartbeat at different temperatures so that possible conditional 
effects of mutations or knockdowns would not be overlooked.  
Here we demonstrate that dysregulation of any of the three calcium-sensing 
proteins would significantly alter cardiac function. More specifically, calpain mutation, 
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calpain knockdown and CaMKII knockdown all result in higher heart rate and more 
regular heartbeat, whereas CaMKII mutation has the opposite effect.  
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Materials and methods 
Drosophila strains, rearing and crosses 
Flies were cultured on a cornmeal-molasses-malt-yeast-agar medium in half-pint 
creamery bottles under uncrowded conditions. Bottles were kept at 25 °C in a 12:12 
light:dark cycle. Wild type Canton-S (CS) strain was used as control groups in all 
experiments. CalpA (ID: 13868) and CalpB (ID: 17422) mutant strains were purchased 
from Drosophila Stock Center at Bloomington (Supplemental Figure 1 and 2). They were 
created by BDGP (Berkeley Drosophila Genome Project) Gene Disruption Project, in 
which genes are disrupted by the insertion of a single transposable element (Bellen et al. 
2004). The l(4)16 strain, which results in CaMKII mutation, was obtained from Erik 
Johnson at the Wake Forest University. The GMH5-Gal4 driver strain and three RNAi 
strains that express double-stranded RNA (dsRNA) for RNA interference of CalpA (ID: 
29455), CalpB (ID: 25963) or CaMKII (ID: 29401) under Upstream Activation Sequence 
(UAS) control were purchased from Drosophila Stock Center at Bloomington as well 
(Supplemental Table 1 – 3). Because previous experiments suggest that most significant 
results were generated by crossing female flies of the RNAi strain with male flies from 
the Gal4 strain (V. Beasley, personal communication), female flies from each of the 
RNAi strains were crossed with male flies from the GMH5-Gal4 strain to create 
knockdown strains –CalpA KD, CalpB KD and CaMKII KD. Flies from the first 
generation of each knockdown strain were tested.  
Heartbeat measurement and temperature protocol 
Fly heartbeat was tested at the P1 stage of pupariation (Ashburner 1989), at which the 
translucent pupae have minimal movement and offer consistent reading. An individual 
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pupa was collected from the side of the culture bottle and placed on a glass slide with 
dorsal side up. A drop of distilled water was added over the pupa to help in equilibrating 
temperature and concentrating the light passing through the sample. The slide was then 
placed under an Olympus BH2 compound microscope (Olympus Optical, Melville, N.Y., 
USA). This preparation is non-invasive and requires no restraint on the animal, allowing 
the heart to be bathed in natural hemolymph and minimizing external errors (Johnson et 
al. 1997). One of the eyepieces of the microscope was modified to fit a phototransistor, 
which monitors changes in light passing through the heart as it beats and produces a 
signal. The signal is pre-amplified with a 741C op-amp (Radio Shack, Fort Worth, Tex., 
USA), amplified with a Grass polygraph (Grass, Warwick, R.I., USA), and uploaded to a 
computer through a Keithley Metrabyte DAS-8 Analog to Digital converter (Metrabyte, 
Taunton, Mass., USA). The temperature of the preparation during testing was monitored 
and controlled by a Sensortek TS-4 unit (Sensortek, Clifton, N.J., USA).  
Following a rigid temperature protocol, the heartbeat of each fly was recorded at 
20, 25, 30, 35 and 37 °C. At each temperature, 90 s of temperature equilibration was 
allowed before the 30 s of recording. The data from the 30 s recording was used 
exclusively for analysis without exception, eliminating possible sampling bias (Dowse et 
al. 1995; Johnson et al. 1997).  
 
Data analysis 
The preliminary data were analyzed to determine heart rate, quantified by frequency 
(FR), and regularity, quantified by rhythmicity index (RI). FR estimates were derived 
from Maximum Entropy Spectral Analysis (MESA) (Ulyrich and Bishop 1975; Dowse 
8 
 
and Ringo 1989; Levine et al. 2002), and the significance is confirmed by inspecting the 
raw signal plot. RI represents the regularity from heartbeat to heartbeat (H. Dowse, 
unpublished data). It is quantified by the autocorrelation function (Chatfield 1980; Dowse 
et al. 1995; Johnson et al. 1998). This function analyzes the correlation of the time series 
with itself when shifted sequentially, or “lagged” out of register, one data point at a time. 
The more irregular the series is, the faster the autocorrelation function declines (Chatfield 
1980). The rhythmicity index (RI) is the height of the third peak, which results from 
shifting the series through two complete cycles, as a fraction of the height of the peak at 
lag zero. The closer this value is to 1.0, the more rhythmic the heartbeat (Dowse et al. 
1995; Dowse 2009).  
Acquired FR and RI data were then analyzed for effects of mutations and 
knockdowns using statistical tests. For flies whose RI was less than 0.085, the heartbeat 
was arbitrarily defined as arrhythmic, and an RI of 0 was assigned. Kruskal-Wallice one-
way analysis of variance with multiple comparison was used for nonparametric test. 
Shapiro-Wilk test was used to test data normality. Parametric test was done using 
multiple comparison with analysis of variance (ANOVA) followed by Tukey’s test (α = 
0.05) (Sokal and Rohlf 1995). Significant differences were analyzed at each individual 
temperature and across temperatures.  
  
9 
 
Results 
Because the Shapiro-Wilk test indicated normal distributions of data at all temperatures, 
only the results of the ANOVA and Tukey’s test were shown here, considering the fact 
that these parametric tests are more efficient and powerful. Specific data are listed in 
Table 1.  
 
Effects of mutations 
Wild type (CS) strain has strong and rhythmic heartbeat at all temperatures (Fig. 1). As 
reported by Jennings et al. (2009), frequency of the heartbeat increases with increasing 
temperature, while rhythmicity index increases then decreases, with peak rhythmicity 
reached between 25 and 30 °C. All three mutations had pronounced effects on FR. 
Compared to wild type, CalpA mutants had significantly higher FR at 20, 25 and 30 °C; 
CalpB mutants had significantly higher FR at all temperatures except 25 °C; and CaMKII 
mutants had significantly lower FR at 35 and 37 °C (Fig. 2). Across temperature analysis 
showed similar results, in which FR was significantly higher in CalpA and CalpB mutant 
strains and significantly lower in CaMKII mutant strains (Fig. 3). 
 None of the mutant strains had significantly different RI at individual 
temperatures (Fig. 4). However, across temperature analysis indicates that CaMKII 
mutants had lower RI than wild type (Fig. 5).   
 
Effects of knockdowns  
Knockdown of CalpA, CalpB, or CaMKII resulted in significantly increased FR at all 
temperatures (Figs. 6, 7).  
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 CalpA KD strain had higher RI at all temperatures except 35 °C. Both CalpB KD 
and CaMKII KD strains had higher RI only at 37 °C (Fig. 8). Nevertheless, all three 
knockdown strains had significantly higher RI across temperatures (Fig. 9). 
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Discussion  
The calcium ion plays a central role in cardiac function, and dysregulation of 
cardiomyocyte Ca2+ homeostasis is directly related to heart disease. However, it remains 
controversial whether this Ca2+ signaling dysregulation is a cause or a result of the 
disease (Anderson 2005). Nevertheless, multiple studies with animal models have found 
that by altering the activity of specific calcium-sensing proteins, the pathological 
condition can be either aggravated or alleviated (References see below). This study 
focused on two calcium-sensing proteins – calpain and Ca2+/calmodulin-dependent 
protein kinase II, and tested the effects of their dysregulation on Drosophila cardiac 
function.  
 The calpain family contains 14 genes in mammals, but only 4 in Drosophila (Goll 
et al. 2003; Friedrich et al. 2004). Out of the four fly calpains, only calpain A and calpain 
B are functional. Calpain C is a truncated version, missing certain domains. With mutated 
active sites, it most likely lacks proteolytic ability. Calpain D is an atypical member that 
is also nonfunctional (Friedrich et al. 2004). Although there exists certain structural 
differences between Drosophila and mammalian calpains, the enzymatic functions are 
highly conserved. Due to the comparatively simple systems and fully analyzed genome 
sequence, studying the calpains in Drosophila heart would shed light on their 
physiological role in human cardiac function.  
 Similarly, CaMKII has highly conserved structure and functions from Drosophila 
through higher vertebrates. For example, the amino acid sequence of CaMKII in 
Drosophila is extremely similar to the one in rat (Supplemental Figure 3), and all the 
autophosphorylation sites are well conserved (Cho et al. 1991). In cardiomyocytes, 
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CaMKII plays a critical regulating role. For instance, it can increase Ca2+ entry by 
phosphorylating L-type Ca2+ channels (Bers, 2002), affect sarcoplasmic reticulum Ca2+ 
transient by phosphorylating ryanodine receptors (Currie et al. 2004) and sarcoplasmic 
endoplasmic reticulum Ca2+ ATPase (SERCA) regulatory protein phospholamban 
(Kranias et al. 1988), and regulates several non-Ca2+ ion transporters as well as 
transcription factor proteins (Anderson 2005). Thus again, it is important to study the 
dysregulation of CaMKII and its role in cardiac pathophysiology.  
 Our evidence shows that, although with some discrepancy at individual 
temperatures, calpain mutations and calpain knockdowns cause significant tachycardia. 
This suggests that calpain might act as a cardio-suppressor in maintaining Ca2+ 
homeostasis, and inhibition or dysregulation of calpain can have a cardio-acceleratory 
effect. Apart from pacemaking regulation, we hypothesize that calpain dysregulation 
might result in decreased contractility, so as a compensating mechanism, the heart beats 
faster to maintain the circulation of hemolymph. However, further investigation involving 
contractility measurement and possibly using an electrophysiological approach is needed 
to confirm this hypothesis.  
 Interestingly, both calpain A and calpain B mutants had slightly more regular 
heartbeat at all temperatures, but no differences were significant. However, this increased 
cardiac rhythmicity became significant in knockdown strains. This finding is congruent 
with several other studies. One study on human atrial fibrillation (AF), the most common 
cardiac arrhythmia, found significantly increased calpain activity in AF patients’ 
cardiomyocytes (Brundel et al. 2002). Essentially, calpain activity correlates with 
structural and electrical remodeling (Brundel et al. 2002; Letavernier et al. 2012). In 
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studies involving mammalian animal models, it was found that inhibiting calpain activity 
attenuates or prevents the development of cardiac arrhythmia or hypertrophy (Patterson et 
al. 2011). In this study, both the mutations and the knockdowns result in a decreased 
amount of active calpain in Drosophila cardiomyocytes, thus leading to the increased 
rhythmicity. Although this result supports that targeted calpain inhibition could 
potentially be used as a therapeutic tool to treat cardiac arrhythmia, it is notable to 
mention that an increased cardiac rhythmicity from baseline is not necessarily beneficial. 
In addition, downstream and long-term effects of calpain inhibition need to be studied 
before further assumptions can be made. 
 CaMKII dysregulation also had significant effects on cardiac frequency and 
rhythmicity. The effects are opposite, however, in mutant strain and knockdown strain. 
Mutant flies had slower heartbeat, and the effect was temperature dependent. Bradycardia 
only appeared at temperature at and above 35 °C. Their heartbeat was also less rhythmic, 
but it was only significantly so when analyzed across temperatures. On the other hand, 
knocking down CaMKII in the heart resulted in increased cardiac frequency and 
rhythmicity. There are several ways to interpret this discrepancy. First, the CaMKII 
mutation comes from a lesion in the CaMKII locus on the l(4)16 chromosome. Instead of 
being a null mutation, it likely produces larger less stable isoforms, resulting in reduced 
amount of functional CaMKII on a systemic level (Johnson et al. 2002). Thus a decreased 
level of functional CaMKII in other tissues or organs might indirectly affect the 
heartbeat. On the other hand, knockdown only reduces CaMKII in the cardiac region, 
eliminating possible interactions with other tissues or organs. Second, reported by 
Johnson et al. (2002), these mutant flies had normal heartbeat, indicating that the 
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different result from this study might be due to the relatively small sample size (N=10). 
Nevertheless, a study using rabbit sinoatrial cells found that suppressing CaMKII activity 
by CaMKII antagonist causes declined heart rate (Vinogradova et al. 2000). Thus, further 
experiment with a larger sample size and possibly a pharmacological approach is needed 
to better understand the results. Third, studies have found that arrhythmia and 
cardiomyopathy are caused by CaMKII overexpression and suppressed by CaMKII 
inhibition (Wu et al. 2002; Anderson 2004; Anderson 2005). This supports the result that 
knocking down CaMKII increases heart rhythmicity.  
 It is notable to mention that because calpain and CaMKII mutations are 
homozygous lethal, all the mutant strains used in this study are heterozygous, and the 
heterozygosity is maintained by a genetic balancer. Thus the effects of mutations should 
be interpreted as a result of incomplete dominance. It is also important to note that the 
three RNAi strains used in this experiment carry a copy of recessive vermilion (v) gene. 
The vermilion mutants are characterized by the lack of brown eye pigment (Shapard 
1958). It was recently found that they express a heart phenotype too, with a slower but 
more rhythmic heartbeat compared to wild type (V. Beasley, unpublished data). In this 
study, the vector that carries the UAS-RNAi has a dominant v[+] allele, which is a 
healthy copy of the vermillion gene. Therefore the visual and cardiac phenotypes are 
rescued.  
 Furthermore, for the knockdown strains in this study, the severity of the 
phenotypes could not be determined due to the lack of data in the current literature. 
However, Ni et al. (2008) reported that the level of post-transcriptional gene silencing 
using this RNAi method depends on sex of the fly, rearing temperature, use of Dicer, 
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number of Gal4 drivers and number of UASs. Thus it is important to focus on these 
variables and determine the expressivity of phenotypes in the future experiments.  
 It is clear that both calpain and CaMKII directly regulate cardiac pacemaking, and 
dysregulation of either would significantly alter the heart rate and rhythmicity. However, 
more work is required to further understand the role of calpain and CaMKII in 
cardiomyocyte. For example, since this study focused on down-regulation, either by 
mutation or knockdown, it is equally important to examine how up-regulation of these 
proteins would affect cardiac function, which can be achieved by inserting an extra copy 
of the gene into the genome. In addition to genetic approaches, a pharmacological 
approach that involves agonists or antagonists injection should also be used to paint a 
more comprehensive picture.  
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Tables and Figures 
 
Table 1 
Table of cardiac frequency (FR) and rhythmicity index (RI) values for various strains  
 
Strain 20 °C 25 °C 30 °C 35 °C 37 °C 
Across 
temp 
CS 1.57 ± 0.14 1.90 ± 0.15 1.91 ± 0.09 2.28 ± 0.09 2.37 ± 0.14 2.00 ± 0.06 
 
0.28 ± 0.11 0.35 ± 0.11 0.41 ± 0.08 0.23 ± 0.09 0.22 ± 0.08 0.30 ± 0.04 
 
5 6 9 6 5 31 
CalpA 2.13 ± 0.10a 2.31 ± 0.10a 2.57 ± 0.10a 2.71 ± 0.13 2.82 ± 0.07 2.50 ± 0.06a 
 
0.57 ± 0.11 0.54 ± 0.09 0.54 ± 0.09 0.52 ± 0.10 0.47 ± 0.08 0.52 ± 0.04 
 
9 10 9 9 9 46 
CalpB 2.01 ± 0.10a 2.24 ± 0.15 2.56 ± 0.06a 2.99 ± 0.14a 3.13 ± 0.11a 2.57 ± 0.07a 
 
0.56 ± 0.11 0.56 ± 0.09 0.62 ± 0.06 0.46 ± 0.11 0.44 ± 0.10 0.53 ± 0.04 
 
8 10 10 8 8 44 
CaMKII 1.51 ± 0.14 1.63 ± 0.13 1.84 ± 0.07 1.73 ± 0.14a 1.68 ± 0.14a 1.67 ± 0.07a 
 
0.27 ± 0.07 0.34 ± 0.07 0.21 ± 0.07 0.16 ± 0.06 0.09 ± 0.03 0.21 ± 0.03b 
 
7 8 7 6 5 33 
       CS 1.63 ± 0.08 1.79 ± 0.07 1.98 ± 0.09 2.15 ± 0.10 2.24 ± 0.11 1.96 ± 0.05 
 
0.49 ± 0.07 0.53 ± 0.06 0.50 ± 0.06 0.42 ± 0.06 0.38 ± 0.06 0.46 ± 0.03 
 
16 19 18 16 17 86 
CalpA KD 2.46 ± 0.05a 2.76 ± 0.05a 3.08 ± 0.07a 3.43 ± 0.09a 3.61 ± 0.11a 3.09 ± 0.06a 
 
0.86 ± 0.03b 0.84 ± 0.02b 0.79 ± 0.04b 0.67 ± 0.06 0.66 ± 0.06b 0.76 ± 0.02b 
 
20 20 20 20 19 99 
CalpB KD 2.25 ± 0.08a 2.37 ± 0.11a 2.57 ± 0.12a 2.88 ± 0.12a 3.05 ± 0.13a 2.63 ± 0.06a 
 
0.64 ± 0.07 0.68 ± 0.06 0.64 ± 0.05 0.60 ± 0.06 0.67 ± 0.06b 0.64 ± 0.03b 
 
18 19 20 19 19 95 
CaMKII KD 2.14 ± 0.10a 2.34 ± 0.12a 2.52 ± 0.13a 2.80 ± 0.16a 3.19 ± 0.13a 2.60 ± 0.07a 
 
0.54 ± 0.08 0.57 ± 0.07 0.61 ± 0.06 0.51 ± 0.07 0.64 ± 0.06b 0.57 ± 0.03b 
 
17 18 20 18 18 91 
 
The first line in each cell contains FR ± SEM, the second contains RI ± SEM, and the third notes the 
number of recordings at that temperature that showed functioning hearts (defined as RI ≥ 0.085). The 
rightmost column contains data summed across all temperatures. Superscripts denote significant 
differences: 
aFR significantly different from wild type (CS) 
bRI significantly different from wild type (CS) 
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Figure 1 
 
 
Figure 1 illustrates the heart beat of a wild type (CS) fly at 20, 25, 30, 35 and 37 °C. Left column: optically 
recorded heartbeat; middle column: spectral analysis (MESA), indicating cardiac frequency (FR); right 
column: autocorrelation function, used to generate rhythmicity index (RI). 
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Figure 2  
 
 
 
Figure 2: When compared to wild type (CS), CalpA mutants had significantly higher frequency (FR) at 20, 
25 and 30 °C; CalpB mutants had significantly higher FR  at all temperatures except 25 °C; and CaMKII 
mutants had significantly lower FR at 35 and 37 °C. 
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Figure 3 
 
 
 
Figure 3: Compared to wild type (CS), frequency (FR) was significantly higher in CalpA and CalpB mutant 
strains and significantly lower in CaMKII mutant strains across temperatures.  
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Figure 4: No significant difference of rhythmicity index (RI) was found between any of the mutant strains 
and the wild type strain.  
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Figure 5 
 
 
 
Figure 5: No significant difference of RI was found between any of the calpain mutants and the wild type 
across temperatures. However, CaMKII mutants had significantly lower RI.  
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Figure 6 
 
 
 
Figure 6: CalpA, CalpB and CaMKII knockdown strains had significantly higher frequency (FR) than CS 
wild type strain at all temperatures.  
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Figure 7 
 
 
 
Figure 7: CalpA, CalpB and CaMKII knockdown strains had significantly higher frequency (FR) than CS 
wild type strain across temperatures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
***	   ***	   ***	  
0.00	  0.50	  
1.00	  1.50	  
2.00	  2.50	  
3.00	  3.50	  
Strains	  
Fr
eq
ue
nc
y	  
(H
z)
	  
Effects	  of	  Knockdown	  on	  Frequency	  	  
(Across	  Temperatures)	  
CS	   CalpA	  KD	   CalpB	  KD	   CaMKII	  KD	  
28 
 
Figure 8 
 
 
 
Figure 8: CalpA knockdown (KD) strain had higher rhythimicity index (RI) than wild type CS strain at all 
temperatures except 35 °C. CalpB KD and CaMKII KD strains had higher RI only at 37 °C.  
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Figure 9 
 
 
 
Figure 9: CalpA, CalpB and CaMKII knockdown (KD) strains had significantly higher rhythmicity index 
(RI) than wild type CS strain across temperatures.  
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Supplemental Tables and Figures 
 
Supplemental Table 1 
CalpA RNAi Information  
Stock number 29455 
Plain text genotype y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03391}attP2 
Genotype with FlyBase 
links y
1 v1; P{TRiP.JF03391}attP2 
Chromosome(s) affected 1;3 
Insertion chromosome(s) 3 
Breakpoints or insertion site 68A4, 3L:11063638..11063638 (R5 flank) 
Date added to collection 12/23/2009 
Donor Transgenic RNAi Project 
Comments Expresses dsRNA for RNAi of CalpA (FBgn0012051) under UAS control, TRiP. 
FlyBase ID FBst0029455 
Date report created 2014-04-25 
 
CalpA RNAi Bloomington Stock Report. (2014). Bloomington Drosophila Stock Center at Indiana 
University. Retrieved from http://flystocks.bio.indiana.edu/Reports/29455.html 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
Supplemental Table 2 
CalpB RNAi Information  
Stock number 25963 
Plain text genotype y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01983}attP2 
Genotype with FlyBase 
links y
1 v1; P{TRiP.JF01983}attP2 
Chromosome(s) affected 1;3 
Insertion chromosome(s) 3 
Breakpoints or insertion site 68A4, 3L:11063638..11063638 (R5 flank) 
Date added to collection 11/24/2008 
Donor Transgenic RNAi Project 
Comments Expresses dsRNA for RNAi of CalpB (FBgn0025866) under UAS control, TRiP. 
FlyBase ID FBst0025963 
Date report created 2014-04-25 
 
CalpB RNAi Bloomington Stock Report. (2014). Bloomington Drosophila Stock Center at Indiana 
University. Retrieved from http://flystocks.bio.indiana.edu/Reports/25963.html 
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Supplemental Table 3 
CaMKII RNAi Information  
Stock number 29401 
Plain text genotype y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03336}attP2 
Genotype with FlyBase 
links y
1 v1; P{TRiP.JF03336}attP2 
Chromosome(s) affected 1;3 
Insertion chromosome(s) 3 
Breakpoints or insertion site 68A4, 3L:11063638..11063638 (R5 flank) 
Date added to collection 12/23/2009 
Donor Transgenic RNAi Project 
Comments Expresses dsRNA for RNAi of CaMKII (FBgn0004624) under UAS control, TRiP. 
FlyBase ID FBst0029401 
Date report created 2014-04-25 
 
CaMKII RNAi Bloomington Stock Report. (2014). Bloomington Drosophila Stock Center at Indiana 
University. Retrieved from http://flystocks.bio.indiana.edu/Reports/29401.html 
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Supplemental Figure 1 
CalpA Flybase Information 
 
 
 
Stock number 13868 
Plain text genotype y[1] w[67c23]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}CalpA[KG05080] 
Genotype with FlyBase 
links y
1 w67c23; P{SUPor-P}CalpAKG05080 
Chromosome(s) affected 1;2 
Insertion chromosome(s) 2 
Breakpoints or insertion 
site 56D5, 2R:15312602..15312602 (R5) 
Date added to collection 4/5/2002 
Donor Berkeley Drosophila Genome Proj. 
Donor's source Hugo J. Bellen 
Comments May be segregating CyO and ry[506], K.C. 7/03 
FlyBase ID FBst0013868 
Date report created 2014-04-25 
 
CalpA Transposable Element Insertion Site. (2014). FlyBase. Retrieved from 
http://flybase.org/reports/FBti0021907.html 
 
CalpA Bloomington Stock Report. (2014). Bloomington Drosophila Stock Center at Indiana University. 
Retrieved from http://flystocks.bio.indiana.edu/Reports/13868.html 
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Supplemental Figure 2 
CalpB Flybase Information 
 
 
 
Stock number 17422 
Plain text genotype y[1] w[67c23]; P{w[+mC] y[+mDint2]=EPgy2}CalpB[EY08042] 
Genotype with FlyBase 
links y
1 w67c23; P{EPgy2}CalpBEY08042 
Chromosome(s) affected 1;3 
Insertion chromosome(s) 3 
Breakpoints or insertion 
site 67D1, 3L:9882209..9882209 (R5) 
Date added to collection 1/16/2004 
Donor Berkeley Drosophila Genome Proj. 
Donor's source Hugo J. Bellen 
FlyBase ID FBst0017422 
Date report created 2014-04-25 
Stock number 17422 
 
CalpB Transposable Element Insertion Site. (2014). FlyBase. Retrieved from 
http://flybase.org/reports/FBti0038789.html 
 
CalpB Bloomington Stock Report. (2014). Bloomington Drosophila Stock Center at Indiana University. 
Retrieved from http://flystocks.bio.indiana.edu/Reports/17422.html 
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Supplemental Figure 3 
Comparison of CaMKII in Drosophila and rat 
 
 
 
Comparison of the Amino Acid Sequences of the Fly α Subunit and the Rat α, β, γ, and δ Subunits. 
Positions with four or more identical residues are boxed, and gaps are dotted. Bars indicate variable regions 
among the CaM kinase subunits.  
 
Cho, K. O., Wall, J. B., Pugh, P. C., Ito, M., Mueller, S. A., & Kennedy, M. B. (1991). The α subunit of 
type II Ca2+/calmodulin-dependent protein kinase is highly conserved in 
Drosophila. Neuron, 7(3), 439-450. 
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